VALANX Biotech
Graz
About VALANX Biotech
VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.2M
- Last round: Series Unknown (Mar 2026)
- Website: valanx.bio
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/valanx-biotech-64871 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.